PATENT CLAIM ANALYSIS

Application Number: 16150759
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "352000"]

Abstract:
A topical pharmaceutical preparation for administering a slightly soluble PDE4 inhibitor is described. A surprisingly good systemic bioavailability is observed with this dosage form.

Claim (Index 23):
The method of  claim 20 , wherein the disease regarded as treatable or preventable through use of PDE 4 inhibitors is selected from the group consisting of psoriasis (vulgaris), toxic and allergic contact eczema, atopic eczema, seborrheic eczema, lichen simplex, sunburn, pruritus in the genitoanal region, alopecia areata, hypertrophic scars, discoid lupus erythematosus, follicular and extensive pyodermas, endogenous and exogenous acne, and acne rosacea.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11885837', '11662887', '10505138', '13008842', '15848505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.755815500218122
- 35 USC 102 Novelty (BERT): 0.494870010021522
- Combined Prediction Score: 0.729720951198462
- Mean Citation Score: 157.52345
- Max Citation Score: 179.21704
- Similarity Product: 113.29240333914755

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test